Edition:
United Kingdom

Kazia Therapeutics Ltd (KZIA.OQ)

KZIA.OQ on NASDAQ Stock Exchange Capital Market

3.00USD
18 Jan 2019
Change (% chg)

$0.32 (+11.94%)
Prev Close
$2.68
Open
$2.80
Day's High
$3.00
Day's Low
$2.78
Volume
1,151
Avg. Vol
967
52-wk High
$6.64
52-wk Low
$2.14

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.05 -0.134
Dec 0.07 0.009
FY 2017 Jun '17 0.11 -0.134
Dec 0.14 -0.092
 
*Note: Units in Millions ofAustralian Dollars
**Note: Units in Australian Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Jun-19 1 13.22 13.22 13.22 13.90
Earnings (per share)
Year Ending Jun-19 1 -57.26 -57.26 -57.26 -133.77
Sales and Profit Figures in Australian Dollar (AUD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 33.71
P/E High - Last 5 Yrs. -- 148.01 49.93
P/E Low - Last 5 Yrs. -- 47.79 24.27
Beta -0.08 1.08 0.90
Price to Sales (TTM) 79.63 49.51 6.28
Price to Book (MRQ) 0.18 10.16 5.27
Price to Tangible Book (MRQ) 2.10 13.82 6.79
Price to Cash Flow (TTM) -- 52.80 24.84
% Owned Institutions 1.59 3.75 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.83
Payout Ratio(TTM) -- 7.04 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -55.57 130.03 9.72
Sales (TTM) vs TTM 1 Yr. Ago -38.66 47.85 5.87
Sales - 5 Yr. Growth Rate -29.68 22.76 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago 82.47 75.87 47.26
EPS (TTM) vs TTM 1 Yr. Ago 55.28 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.82
Capital Spending - 5 Yr. Growth Rate 63.40 9.24 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.26
Current Ratio (MRQ) 3.62 3.43 3.08
LT Debt to Equity (MRQ) 0.00 18.73 11.38
Total Debt to Equity (MRQ) 0.00 31.43 16.13
Interest Coverage (TTM) -381,217.00 -43.27 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.29 53.78
Gross Margin - 5 Yr. Avg. -- 60.55 52.17
EBITD Margin (TTM) -6,924.99 -- --
EBITD - 5 Yr. Avg -2,506.94 -110.23 12.87
Operating Margin (TTM) -7,495.51 -184.42 6.20
Operating Margin - 5 Yr. Avg. -2,718.78 -126.67 8.31
Pre-Tax Margin (TTM) -4,367.83 -175.20 7.17
Pre-Tax Margin - 5 Yr. Avg. -2,028.72 -132.83 8.61
Net Profit Margin (TTM) -4,288.05 -181.93 3.30
Net Profit Margin - 5 Yr. Avg. -2,018.50 -137.23 4.88
Effective Tax Rate (TTM) -- 21.48 22.88
Effective Tax Rate - 5 Yr. Avg. -- 15.57 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,650,695 844,239,566
Net Income/Employee (TTM) -- 652,572 100,064,145
Receivable Turnover (TTM) 0.11 6.25 5.72
Inventory Turnover (TTM) -- 1.89 3.48
Asset Turnover (TTM) 0.01 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -29.88 6.45 11.08
Return on Assets - 5 Yr. Avg. -34.24 5.52 12.21
Return on Investment (TTM) -33.03 8.99 14.48
Return on Investment - 5 Yr. Avg. -38.70 6.85 15.88
Return on Equity (TTM) -36.01 10.13 15.99
Return on Equity - 5 Yr. Avg. -39.42 8.39 17.00
  1 Year 3 Year 5 Year
Sales % -38.66 42.12 -29.68
EPS (TTM) % 79.79 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Kazia Therapeutics Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -1.88 -5.26 33 99
13 Week -13.09 -17.32 26 95
26 Week -28.12 -33.59 23 98
52 Week -60.76 -66.74 13 72
YTD -48.98 -55.19 11 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 2.60%
# of Holders: 10
Total Shares Held: 125,682
3 Mo. Net Change: -550
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.